Baxter reported Q4 adjusted EPS of $0.58, beating the $0.52 consensus and its own guidance of $0.50-$0.53. Baxter forecasts 2025 sales growth of 5%-6% and adjusted EPS of $2.45-$2.55, with Q1 2025 ...
Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective immediately — an announcement that came just days after the company sold ...
Purpose: Results of published, randomized controlled trials comparing sevoflurane and desflurane were pooled to measure differences in times until patients obeyed commands, were extubated ...
Baxter International’s BAX3.73%increase; green up pointing triangle long-time leader, Jose Almeida, has abruptly retired as chairman, president and chief executive of the medical-products maker ...
Gifting allows recipients to access the article for free. Baxter International’s longtime CEO and board chair, José Almeida, is stepping down and retiring, effective immediately, the medical ...
Investing.com -- Baxter International Inc. (NYSE:BAX), a global leader in medical technology, announced today the immediate retirement of José (Joe) E. Almeida, the company's chair, president ...
DEERFIELD, Ill., February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief ...
Baxter (BAX) announced that Jose Almeida, chair, president and CEO, will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through ...
Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its acquisition by funds managed by global investment firm ...
Although the 2015 Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With ...
Feb 3 (Reuters) - Medical products maker Baxter International (BAX.N), opens new tab said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's ...
Baxter announced that long-time CEO, Joe Almeida, was retiring immediately without a successor in place, while suggesting that its 2025 guidance would likely decline due to new US tariffs on China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results